Change over period: —
NSE · DEEPAKNTR
DEEPAKNTR
-16.7% from the 52-week high · +21.5% above the low
Deepak Nitrite Ltd. operates as a chemical manufacturing company, which engages in the manufacture and sale of chemicals. The company is headquartered in Vadodara, Gujarat and currently employs 1,694 full-time employees. The company went IPO on 2010-09-28. The firm's segments include Basic Chemicals, Fine & Speciality Chemicals, Performance Products and Phenolics. The Basic Chemicals segment offers sodium nitrite, sodium nitrate, nitro toluidines, fuel additives, and nitrosyl sulphuric acid. The Fine & Speciality Chemicals segment offers xylidines, oximes, cumidines, and speciality agrochemicals. Its Performance Products include optical brightening agent (OBA) and diamino stilbene disulfonic acid (DASDA). Its Phenolics offers phenol, acetone, cumene, and isopropyl alcohol. The firm's products cater to several industries, such as colorants, petrochemicals, agrochemicals, rubber, pharmaceuticals, paper, textile and detergents. The firm's manufacturing facilities are located at Nandesari, Dahej (Gujarat), Roha, Taloja (Maharashtra) and Hyderabad (Telangana), and its research and development facility is located at Nandesari (Gujarat).
The short version. DEEPAKNTR reported revenue of ₹3,076 crore for Sep 2026, up 61.7% from a year earlier. Net profit was ₹398 crore (up 234.5% year on year). Return on equity was 9.4% in Mar 2026. Promoter holding was 49.39% in Sep 2026, up 0.15 points over 8 quarters.
1 · The price
How has the stock traded?
DEEPAKNTR trades 16.7% below its 52-week high and 21.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹3,076 cr.
Sep 2026 net profit of ₹398 cr.
6.7 pts higher than a year earlier.
Revenue compounded at -0.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3076 | 2578 | 2120 | 1975 | 1902 | 1890 | 2180 | 1903 |
| Net profit | 398 | 345 | 220 | 100 | 119 | 112 | 202 | 98 |
| Net margin % | 12.9 | 13.4 | 10.4 | 5.1 | 6.2 | 5.9 | 9.3 | 5.2 |
| EPS (₹) | 29.16 | 25.3 | 16.11 | 7.32 | 8.7 | 8.23 | 14.84 | 7.19 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7887 | 8282 | 7682 | 7972 | 6802 | 4360 | 4230 | 2700 |
| Net profit | 551 | 697 | 811 | 852 | 1067 | 776 | 611 | 174 |
| Net margin % | 7.0 | 8.4 | 10.6 | 10.7 | 15.7 | 17.8 | 14.4 | 6.4 |
| EPS (₹) | 40.36 | 51.12 | 59.45 | 62.47 | 78.2 | 56.88 | 44.8 | 12.73 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 9.4% in Mar 2026; debt to equity is 0.26.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 9.4 | 12.9 | 16.9 | 20.8 |
| Return on capital % | 10.8 | 14.4 | 21.0 | 27.0 |
| EBITDA margin % | 12.9 | 14.1 | 16.5 | 16.7 |
| Net margin % | 6.9 | 8.3 | 10.4 | 10.6 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -0.3% | 12.7% |
| Profit CAGR | -13.6% | -6.6% |
4 · The owners
Who holds it, and are they adding?
Up 0.15 pts over 8 quarters.
Down 0.2 pts over 8 quarters.
Down 0.72 pts over 8 quarters.
+13 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.24 | 49.28 | 49.28 | 49.28 | 49.33 | 49.33 | 49.34 | 49.39 | +0.15 |
| FII | 6.6 | 6.65 | 6.68 | 6.21 | 6.05 | 6.19 | 6.25 | 6.4 | -0.2 |
| DII | 23.22 | 23.22 | 22.62 | 22.7 | 23.2 | 23.47 | 23.76 | 22.5 | -0.72 |
| Public | 20.94 | 20.85 | 21.42 | 21.81 | 21.42 | 21.01 | 20.65 | 21.71 | +0.77 |
Mutual fund holdings · Oct 2026
84 schemes hold this stock
71 the month before.
- SBI Long Term Advantage Fund - Series VI4.48% of NAV
- Kotak Nifty Chemicals ETF3.15% of NAV
- Groww Nifty Chemicals ETF3.15% of NAV
- Invesco India Nifty Chemical Index Fund3.09% of NAV
- SBI Comma Fund1.97% of NAV
- Nippon India Active Momentum Fund1.88% of NAV
- Franklin India Small Cap Fund1.87% of NAV
- Franklin India Mid Cap Fund1.44% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for DEEPAKNTR are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about DEEPAKNTR
What is the DEEPAKNTR share price?
DEEPAKNTR (DEEPAKNTR) last closed at ₹1,550.00, down 0.83% on the day. Its 52-week range is ₹1,286.80 to ₹1,875.90.
What is the market cap of DEEPAKNTR?
DEEPAKNTR has a market capitalisation of about ₹21,294 crore. Its price-to-earnings ratio is 20.3.
How are DEEPAKNTR's latest results?
DEEPAKNTR reported revenue of ₹3,076 crore for Sep 2026, up 61.7% from a year earlier. Net profit was ₹398 crore (up 234.5% year on year). Return on equity was 9.4% in Mar 2026. Promoter holding was 49.39% in Sep 2026, up 0.15 points over 8 quarters.
Who owns DEEPAKNTR?
As of Sep 2026, shareholding was: Promoter 49.39%, FII 6.4%, DII 22.5%, Public 21.71%.
How many mutual funds hold DEEPAKNTR?
84 mutual fund schemes held DEEPAKNTR in October 2026. That compares with 71 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 04 Aug 2025 · Dividend - Rs. 7.5
- 29 Jul 2024 · Dividend - Rs. 7.5
- 27 Jul 2023 · Final Dividend - Rs. 7.5
- 25 Jul 2022 · Dividend - Rs. 7
- 20 Jul 2021 · Dividend - Rs. 4.5
- 20 Jul 2021 · Special Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.